Gringeri, A. Et Al. 2011. The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors. HAEMOPHILIA , vol.17, no.2 , 363.

Gringeri, A., Antmen, B., Berntorp, E., Biasioli, C., Carpenter, S., Kavakli, K., ... Lassila, R.(2011). The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors. HAEMOPHILIA , vol.17, no.2, 363.

Gringeri, A. Et Al. "The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors," HAEMOPHILIA , vol.17, no.2, 363, 2011

Gringeri, A. Et Al. "The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors." HAEMOPHILIA , vol.17, no.2, pp.363, 2011

Gringeri, A. Et Al. (2011) . "The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors." HAEMOPHILIA , vol.17, no.2, p.363.

@article{article, author={A. Gringeri Et Al. }, title={The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors}, journal={HAEMOPHILIA}, year=2011, pages={363} }